skip to Main Content
480.314.3070
Daniel Von Hoff

Daniel D Von Hoff, M.D., F.A.C.P.

Chairman

Physician in Chief and Director of Translational Research at TGen. Chief Scientific Officer for US Oncology and for HonorHealth Clinical Research Institute. Clinical Professor of Medicine, University of Arizona. Serves…   Read More

Bruce D Cheson

Bruce D. Cheson, M.D., F.A.C.P., F.A.A.S.

Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital. Chairs the Lymphoma Committee of the Cancer and Leukemia Group B and the AJCC Subcommittee…   Read More

Robert Ford

Robert R. Ford, M.D.

Radiologist at Carrier Clinic and Princeton University, and an Attending Radiologist at University Medical Center at Princeton. Founded and was President/CMO of RadPharm. Supervised the independent radiologic review of images…   Read More

David Sidransky

David Sidransky, M.D.

Director of the Head and Neck Cancer Research at Johns Hopkins School of Medicine and Professor of Oncology, Otolaryngology, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at John Hopkins…   Read More

Manuel Hidalgo

Manuel Hidalgo, M.D., PhD.

Recently appointed Director of Leon V. & Marilyn L. Rosenberg Clinical Cancer Center and Chief of the Division of Hematology-Oncology at Beth Israel Deaconess Medical Center (BIDMC). Currently Head of…   Read More

Additionally, we are pleased to have a panel of world-renowned Key Opinion Leaders (KOLs) that assist with the design and implementation of imaging in clinical trials.

These KOLs include:

Sunil Sharma M.D. Professor and division director of Applied Cancer Research and Drug Discovery at TGen, Chief of Oncology Research and Drug Discovery at HonorHealth, and formerly of the Huntsman Cancer Institute.

Haesun Choi M.D. Clinical Professor at MD Anderson and developer of the Choi criteria.

Phil Kuo M.D., PhD. Chair of Radiology and PET at the University of Arizona with expertise in developing novel approaches to targeted imaging agents.

Michael Gordon M.D. Oncologist at HonorHealth with expertise in anti-vascular, immunotherapy drug development.

Benjamin Ellingson, PhD. Author of the modified RANO criteria designed to better address pseudo-progression.

Richard Sparks, PhD., DVM, MA, MBA, MS President and Senior Scientist, CDE Dosimetry Services and former image quantification and internal dosimetry consultant to the FDA.

Jonathan Nye, PhD. Assistant Professor and Program Director for PET Research at the Center for Systems Imaging, Emory University School of Medicine.

Back To Top